Nf-Kappa B Inhibitors As A Novel Therapeutic Agent In The Acute Phase Of Kawasaki Disease
Circulation(2018)
摘要
Introduction: Kawasaki disease (KD), which is the most common multisystem vasculitis with unknown causes in childhood, causes coronary artery aneurysms (CAAs). Infliximab (IFX), anti-human TNF-α mo...
更多查看译文
关键词
kawasaki disease,novel therapeutic agent,inhibitors,nf-kappa
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要